Biblio Discovery — Demo Discovery Service

4 hasil untuk "Divya Balan"

Menampilkan 1–4 · 0,21 detik · RSS

  1. Artikel Jurnal

    Monitoring COPD patients systemic and bronchial eosinophilic inflammation in a 2-year follow-up: few concerns

    Divya Balan; Mohan K. Manu

    BMC Pulmonary Medicine, Vol. 25 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract Monitoring COPD patients: systemic and bronchial eosinophilic inflammation in a 2-year follow-up" by Pignatti et al. provides valuable insights about changes in blood and sputum eosinophils in mild to moderate COPD patients and treatment outcomes. However, concerns arise regarding the…

  2. Artikel Jurnal

    Bronchodilator reversibility testing in morbidly obese non-smokers: a comparative study– few concerns

    Divya Balan; Manish R Shetty; Manu K Mohan

    BMC Pulmonary Medicine, Vol. 24 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract This is a letter in response to an article by Ahmed et al., which concluded that in comparison to salbutamol, Fluticasone/salmeterol combination increases FEV1, FEV1% of predicted, and FEV1/FVC ratio, however it did not offer novel insights, as both agents met the 12%- and 200-mL…

  3. Artikel Jurnal

    Comparison of Efficacy and Safety of Talc to Povidone-Iodine Pleurodesis in Malignant Pleural Effusion: A Systematic Review and Meta-Analysis

    Divya Balan; Tejaswini Baral; Mohan K. Manu dkk.

    Indian Journal of Medical and Paediatric Oncology, Vol. 46 No. 01 · 2025 · Inggris · DOAJ Scopus

    Malignant pleural effusion (MPE) poses a substantial clinical challenge, necessitating effective interventions. Pleurodesis, commonly employed in MPE management, involves inducing pleural symphysis to prevent fluid accumulation. Talc and povidone-iodine have emerged as prominent agents for…

  4. Artikel Jurnal

    Efficacy of probiotics as adjuvant therapy in bronchial asthma: a systematic review and meta-analysis

    Divya Balan; Tejaswini Baral; Mohan K. Manu dkk.

    Allergy, Asthma & Clinical Immunology, Vol. 20 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Background Asthma is a chronic, heterogeneous disease characterized by airway inflammation. Asthma exacerbations significantly increase the disease burden, necessitating new therapeutic approaches. Emerging evidence suggests probiotics, through the gut-lung axis, may benefit asthma…